---
title: "Ningbo David Medical Device Co., Ltd. (300314.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300314.SZ.md"
symbol: "300314.SZ"
name: "Ningbo David Medical Device Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-20T15:25:23.575Z"
locales:
  - [en](https://longbridge.com/en/quote/300314.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300314.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300314.SZ.md)
---

# Ningbo David Medical Device Co., Ltd. (300314.SZ)

## Company Overview

Ningbo David Medical Device Co., Ltd. engages in the research and development, production, and sales of pediatric childcare equipment, surgical instruments and other products worldwide. The company provides infant incubators, transport incubators, infant radiant warmers, neonate bilirubin phototherapy equipment, infant resuscitators, etc. It offers infusion pumps, transcutaneous jaundice detectors, infant t-piece resuscitators, air/oxygen blenders, low pressure aspirators, and infant oxygen hoods.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.nbdavid.com](https://www.nbdavid.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:09.000Z

**Overall: B (0.33)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 25 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 16.80% |  |
| Net Profit YoY | 78.25% |  |
| P/B Ratio | 2.63 |  |
| Dividend Ratio | 1.47% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3271729109.91 |  |
| Revenue | 576688120.06 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 6.11% | C |
| Profit Margin | 12.92% | B |
| Gross Margin | 49.92% | B |
| Revenue YoY | 16.80% | B |
| Net Profit YoY | 78.25% | A |
| Total Assets YoY | 4.67% | C |
| Net Assets YoY | 4.24% | C |
| Cash Flow Margin | 112.99% | C |
| OCF YoY | 16.80% | B |
| Turnover | 0.41 | C |
| Gearing Ratio | 14.34% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Ningbo David Medical Device Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "16.80%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "78.25%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "2.63",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.47%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3271729109.91",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "576688120.06",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "6.11%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "12.92%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "49.92%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "16.80%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "78.25%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "4.67%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.24%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "112.99%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "16.80%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.41",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "14.34%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 42.56 | 25/64 | 86.01 | 61.65 | 55.29 |
| PB | 2.55 | 27/64 | 3.38 | 3.21 | 2.99 |
| PS (TTM) | 5.50 | 25/64 | 7.97 | 7.59 | 7.08 |
| Dividend Yield | 1.52% | 19/64 | 0.69% | 0.64% | 0.61% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## Institutional View

### Analyst Rating Distribution

> As of 2024-04-28T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 1 | 100% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 10.99 |
| Highest Target | undefined |
| Lowest Target | undefined |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/300314.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/300314.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/300314.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/300314.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**